135 related articles for article (PubMed ID: 7720037)
1. Comparative pathology of mammary tumorigenesis in transgenic mice.
Cardiff RD; Munn RJ
Cancer Lett; 1995 Mar; 90(1):13-9. PubMed ID: 7720037
[TBL] [Abstract][Full Text] [Related]
2. The biology of mammary transgenes: five rules.
Cardiff RD
J Mammary Gland Biol Neoplasia; 1996 Jan; 1(1):61-73. PubMed ID: 10887481
[TBL] [Abstract][Full Text] [Related]
3. Transgenic oncogene mice. Tumor phenotype predicts genotype.
Cardiff RD; Sinn E; Muller W; Leder P
Am J Pathol; 1991 Sep; 139(3):495-501. PubMed ID: 1887859
[TBL] [Abstract][Full Text] [Related]
4. Mammary tumorigenesis and metastasis in transgenic mice.
Webster MA; Muller WJ
Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
Kitsberg DI; Leder P
Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
[TBL] [Abstract][Full Text] [Related]
7. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
[TBL] [Abstract][Full Text] [Related]
8. In vivo evidence supporting a metastasis suppressor role for Stard13 (Dlc2) in ErbB2 (Neu) oncogene induced mouse mammary tumors.
Basak P; Leslie H; Dillon RL; Muller WJ; Raouf A; Mowat MRA
Genes Chromosomes Cancer; 2018 Apr; 57(4):182-191. PubMed ID: 29218825
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
Kirma N; Gill K; Mandava U; Tekmal RR
Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
[TBL] [Abstract][Full Text] [Related]
10. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of transgenic mouse mammary tumors (a short atlas).
Munn RJ; Webster M; Muller WJ; Cardiff RD
Semin Cancer Biol; 1995 Jun; 6(3):153-8. PubMed ID: 7495983
[TBL] [Abstract][Full Text] [Related]
12. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
Zhao H; Cui Y; Dupont J; Sun H; Hennighausen L; Yakar S
Cancer Res; 2005 Aug; 65(15):6864-73. PubMed ID: 16061670
[TBL] [Abstract][Full Text] [Related]
14. Expression of activated oncogenes in the murine mammary gland: transgenic models for human breast cancer.
Muller WJ
Cancer Metastasis Rev; 1991 Oct; 10(3):217-27. PubMed ID: 1662559
[TBL] [Abstract][Full Text] [Related]
15. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice.
Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED
Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449
[TBL] [Abstract][Full Text] [Related]
16. Proto-neoplasia revisited: the molecular biology of mouse mammary hyperplasia.
Cardiff RD; Aguilar-Cordova E
Anticancer Res; 1988; 8(5A):925-33. PubMed ID: 2845853
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mouse models of mammary tumorigenesis.
Cardiff RD; Muller WJ
Cancer Surv; 1993; 16():97-113. PubMed ID: 8394206
[No Abstract] [Full Text] [Related]
18. Induction of mammary epithelial hyperplasias and mammary tumors in transgenic mice expressing a murine mammary tumor virus/activated c-src fusion gene.
Webster MA; Cardiff RD; Muller WJ
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7849-53. PubMed ID: 7544006
[TBL] [Abstract][Full Text] [Related]
19. Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue.
Tennant RW; Rao GN; Russfield A; Seilkop S; Braun AG
Carcinogenesis; 1993 Jan; 14(1):29-35. PubMed ID: 8093862
[TBL] [Abstract][Full Text] [Related]
20. Mammary gland neoplasia: insights from transgenic mouse models.
Siegel PM; Hardy WR; Muller WJ
Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
